<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Submission to Health Committee accountability hearing with the General Medical Council, December 2013</title></head><body><div><p style="margin:0pt"><span style="font-family:Cambria; font-size:12pt">&#xa0;</span></p><p style="margin:0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Written evidence from </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Dr Ben </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Goldacre</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">, Sir Iain Chalmers, Dr Trish Groves</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">, Dr Fiona </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Godlee</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">, Dr Virginia Barbour (GMC0019)</span></p><p style="margin:0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Ben </span><span style="font-family:'Times New Roman'; font-size:12pt">Goldacre</span><span style="font-family:'Times New Roman'; font-size:12pt"> is a medic </span><span style="font-family:'Times New Roman'; font-size:12pt">and </span><span style="font-family:'Times New Roman'; font-size:12pt">academic who writes </span><span style="font-family:'Times New Roman'; font-size:12pt">for the </span><span style="font-family:'Times New Roman'; font-size:12pt">public on misuses of scientific evidence</span><span style="font-family:'Times New Roman'; font-size:12pt">, including a recent book </span><span style="font-family:'Times New Roman'; font-size:12pt">about </span><span style="font-family:'Times New Roman'; font-size:12pt">problems in medicine [1]</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span><span style="font-family:'Times New Roman'; font-size:12pt">Iain Chalmers is co-founder of the Cochrane Collaboration, and director of the James Lind Library. Trish Groves is </span><span style="font-family:'Times New Roman'; font-size:12pt">a medic and </span><span style="font-family:'Times New Roman'; font-size:12pt">Deputy Editor of the British Me</span><span style="font-family:'Times New Roman'; font-size:12pt">dical Journal. </span><span style="font-family:'Times New Roman'; font-size:12pt">Fiona </span><span style="font-family:'Times New Roman'; font-size:12pt">Godlee</span><span style="font-family:'Times New Roman'; font-size:12pt"> is </span><span style="font-family:'Times New Roman'; font-size:12pt">a medic and </span><span style="font-family:'Times New Roman'; font-size:12pt">Editor in Chief of the British Medical Journal. Virgin</span><span style="font-family:'Times New Roman'; font-size:12pt">i</span><span style="font-family:'Times New Roman'; font-size:12pt">a Barbour is </span><span style="font-family:'Times New Roman'; font-size:12pt">a medic and </span><span style="font-family:'Times New Roman'; font-size:12pt">Editor in Chief of </span><span style="font-family:'Times New Roman'; font-size:12pt">PLoS</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">Medicine</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span><span style="font-family:'Times New Roman'; font-size:12pt">All are </span><span style="font-family:'Times New Roman'; font-size:12pt">also</span><span style="font-family:'Times New Roman'; font-size:12pt"> co-founder</span><span style="font-family:'Times New Roman'; font-size:12pt">s</span><span style="font-family:'Times New Roman'; font-size:12pt"> of </span><span style="font-family:'Times New Roman'; font-size:12pt">AllTrials</span><span style="font-family:'Times New Roman'; font-size:12pt">, a campaign </span><span style="font-family:'Times New Roman'; font-size:12pt">with widespread public and professional support </span><span style="font-family:'Times New Roman'; font-size:12pt">c</span><span style="font-family:'Times New Roman'; font-size:12pt">alling for all trial results on currently used treatments to be made publicly available</span><span style="font-family:'Times New Roman'; font-size:12pt"> [</span><span style="font-family:'Times New Roman'; font-size:12pt">2</span><span style="font-family:'Times New Roman'; font-size:12pt">]</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">We are </span><span style="font-family:'Times New Roman'; font-size:12pt">writing to raise three areas where the assistance of the GMC would be very valuable to patients and the public</span><span style="font-family:'Times New Roman'; font-size:12pt">, and where such intervention is timely</span><span style="font-family:'Times New Roman'; font-size:12pt">.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">1.</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold"> P</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">romoting p</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">articipat</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">ion </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">in research.</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The GMC guidance previously stated that doctors “</span><span style="font-family:'Times New Roman'; font-size:12pt">must work with colleagues and patients . . . to help resolve uncertainties about the effects of treatments” (</span><span style="font-family:'Times New Roman'; font-size:12pt">para</span><span style="font-family:'Times New Roman'; font-size:12pt"> 14f)</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span><span style="font-family:'Times New Roman'; font-size:12pt">However, in </span><span style="font-family:'Times New Roman'; font-size:12pt">2013 </span><span style="font-family:'Times New Roman'; font-size:12pt">the GMC </span><span style="font-family:'Times New Roman'; font-size:12pt">removed </span><span style="font-family:'Times New Roman'; font-size:12pt">this clause</span><span style="font-family:'Times New Roman'; font-size:12pt"> [3]</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span><span style="font-family:'Times New Roman'; font-size:12pt">T</span><span style="font-family:'Times New Roman'; font-size:12pt">his decision should be reversed, and the clause reinstated</span><span style="font-family:'Times New Roman'; font-size:12pt">. Research is the only way we can identify and reduce uncertainty about which treatments work best. At present there is considerable red tape obstructing doctors who seek to conduct research</span><span style="font-family:'Times New Roman'; font-size:12pt">. M</span><span style="font-family:'Times New Roman'; font-size:12pt">uc</span><span style="font-family:'Times New Roman'; font-size:12pt">h of </span><span style="font-family:'Times New Roman'; font-size:12pt">this red tape </span><span style="font-family:'Times New Roman'; font-size:12pt">is unnecessary; the incentives to participate in research do not reflect the urgency of the </span><span style="font-family:'Times New Roman'; font-size:12pt">need for better evidence to guide clinical practice</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span><span style="font-family:'Times New Roman'; font-size:12pt">T</span><span style="font-family:'Times New Roman'; font-size:12pt">here are many documented cases where patients have suffered and died unnecessarily</span><span style="font-family:'Times New Roman'; font-size:12pt">,</span><span style="font-family:'Times New Roman'; font-size:12pt"> because</span><span style="font-family:'Times New Roman'; font-size:12pt"> doctors </span><span style="font-family:'Times New Roman'; font-size:12pt">have </span><span style="font-family:'Times New Roman'; font-size:12pt">failed to </span><span style="font-family:'Times New Roman'; font-size:12pt">recognise</span><span style="font-family:'Times New Roman'; font-size:12pt"> uncertainty</span><span style="font-family:'Times New Roman'; font-size:12pt"> and conduct research to address it</span><span style="font-family:'Times New Roman'; font-size:12pt"> [3]</span><span style="font-family:'Times New Roman'; font-size:12pt">. The GMC requires doctors to practice medicine based on research evidence. </span><span style="font-family:'Times New Roman'; font-size:12pt">We cannot </span><span style="font-family:'Times New Roman'; font-size:12pt">do so </span><span style="font-family:'Times New Roman'; font-size:12pt">without </span><span style="font-family:'Times New Roman'; font-size:12pt">producing </span><span style="font-family:'Times New Roman'; font-size:12pt">this </span><span style="font-family:'Times New Roman'; font-size:12pt">evidence, and doctors have a responsibility to </span><span style="font-family:'Times New Roman'; font-size:12pt">all </span><span style="font-family:'Times New Roman'; font-size:12pt">patien</span><span style="font-family:'Times New Roman'; font-size:12pt">ts to help identify and reduce uncertainty in everyday clinical practice.</span><span style="font-family:'Times New Roman'; font-size:12pt"> This should be </span><span style="font-family:'Times New Roman'; font-size:12pt">unambiguously </span><span style="font-family:'Times New Roman'; font-size:12pt">reflected in GMC guidance</span><span style="font-family:'Times New Roman'; font-size:12pt">, as it was until 2013</span><span style="font-family:'Times New Roman'; font-size:12pt">.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">2. A register for doctors’ conflicts of interest</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">There is a need for a register of doctors' </span><span style="font-family:'Times New Roman'; font-size:12pt">c</span><span style="font-family:'Times New Roman'; font-size:12pt">onflicts o</span><span style="font-family:'Times New Roman'; font-size:12pt">f </span><span style="font-family:'Times New Roman'; font-size:12pt">i</span><span style="font-family:'Times New Roman'; font-size:12pt">nterest, similar that for MP's. At present, doctors may receive </span><span style="font-family:'Times New Roman'; font-size:12pt">consultancy </span><span style="font-family:'Times New Roman'; font-size:12pt">income, </span><span style="font-family:'Times New Roman'; font-size:12pt">research </span><span style="font-family:'Times New Roman'; font-size:12pt">funding, sponsorship, travel, hospitality and free educational activity sponsored by the pharmaceutical and device industries</span><span style="font-family:'Times New Roman'; font-size:12pt">; m</span><span style="font-family:'Times New Roman'; font-size:12pt">any doctors serving on Clinical </span><span style="font-family:'Times New Roman'; font-size:12pt">Commissioning Groups now run companies whose services are commissioned by their own CCG</span><span style="font-family:'Times New Roman'; font-size:12pt">; m</span><span style="font-family:'Times New Roman'; font-size:12pt">any media doctors receive income from PR or medical companies</span><span style="font-family:'Times New Roman'; font-size:12pt">; and so on</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">C</span><span style="font-family:'Times New Roman'; font-size:12pt">onflicts of interest cannot be prevented, nor would it be desirable to do so: there is mu</span><span style="font-family:'Times New Roman'; font-size:12pt">ch good work done by doctors collaborating with industry. </span><span style="font-family:'Times New Roman'; font-size:12pt">These payments </span><span style="font-family:'Times New Roman'; font-size:12pt">also </span><span style="font-family:'Times New Roman'; font-size:12pt">do not mean that doctors are corrupt. However, t</span><span style="font-family:'Times New Roman'; font-size:12pt">here is extensive research evidence showing that </span><span style="font-family:'Times New Roman'; font-size:12pt">doctors with financial </span><span style="font-family:'Times New Roman'; font-size:12pt">conflicts of interest </span><span style="font-family:'Times New Roman'; font-size:12pt">often </span><span style="font-family:'Times New Roman'; font-size:12pt">express </span><span style="font-family:'Times New Roman'; font-size:12pt">more </span><span style="font-family:'Times New Roman'; font-size:12pt">favourable</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">views on </span><span style="font-family:'Times New Roman'; font-size:12pt">the </span><span style="font-family:'Times New Roman'; font-size:12pt">treatments</span><span style="font-family:'Times New Roman'; font-size:12pt"> in question</span><span style="font-family:'Times New Roman'; font-size:12pt">,</span><span style="font-family:'Times New Roman'; font-size:12pt"> when compared to </span><span style="font-family:'Times New Roman'; font-size:12pt">doctors who have not received such payments</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span><span style="font-family:'Times New Roman'; font-size:12pt">I</span><span style="font-family:'Times New Roman'; font-size:12pt">t is </span><span style="font-family:'Times New Roman'; font-size:12pt">therefore </span><span style="font-family:'Times New Roman'; font-size:12pt">important that information about these conflicts of interest is transparent</span><span style="font-family:'Times New Roman'; font-size:12pt">. It</span><span style="font-family:'Times New Roman'; font-size:12pt"> is currently extremely hard - and in many cases impossible - </span><span style="font-family:'Times New Roman'; font-size:12pt">for patients, colleagues, </span><span style="font-family:'Times New Roman'; font-size:12pt">patients </span><span style="font-family:'Times New Roman'; font-size:12pt">and the public to establish who </span><span style="font-family:'Times New Roman'; font-size:12pt">has paid</span><span style="font-family:'Times New Roman'; font-size:12pt"> a doctor.</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Industry and self-</span><span style="font-family:'Times New Roman'; font-size:12pt">regulatory approaches to this have failed, and will most likely to continue to do so. The Ethical Standards in Health and Life Sciences Group (co-chai</span><span style="font-family:'Times New Roman'; font-size:12pt">red by the ABPI and the Royal College of Physicians) is a particularly concerning example: they produced "guidelines" documents for doctors which contained a number of false claims, and gave false reassurance on important matters of patient safety, before </span><span style="font-family:'Times New Roman'; font-size:12pt">disbanding</span><span style="font-family:'Times New Roman'; font-size:12pt"> in October 2013</span><span style="font-family:'Times New Roman'; font-size:12pt">, </span><span style="font-family:'Times New Roman'; font-size:12pt">without ever giving </span><span style="font-family:'Times New Roman'; font-size:12pt">a clear account of their activities</span><span style="font-family:'Times New Roman'; font-size:12pt"> [4] [5] [6]</span><span style="font-family:'Times New Roman'; font-size:12pt">. Furthermore, declarations of payments to doctors from the pharmaceutical industry </span><span style="font-family:'Times New Roman'; font-size:12pt">(which has often been proposed, but never delivered) </span><span style="font-family:'Times New Roman'; font-size:12pt">would be</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">insufficient, a</span><span style="font-family:'Times New Roman'; font-size:12pt">s </span><span style="font-family:'Times New Roman'; font-size:12pt">this sector </span><span style="font-family:'Times New Roman'; font-size:12pt">cover</span><span style="font-family:'Times New Roman'; font-size:12pt">s</span><span style="font-family:'Times New Roman'; font-size:12pt"> only a small proportion of the many sources of </span><span style="font-family:'Times New Roman'; font-size:12pt">payments to </span><span style="font-family:'Times New Roman'; font-size:12pt">doctors</span><span style="font-family:'Times New Roman'; font-size:12pt">, as</span><span style="font-family:'Times New Roman'; font-size:12pt"> described above</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The GMC requires doctors to re-register each year, </span><span style="font-family:'Times New Roman'; font-size:12pt">and </span><span style="font-family:'Times New Roman'; font-size:12pt">maintains a public register</span><span style="font-family:'Times New Roman'; font-size:12pt">. It is therefore </span><span style="font-family:'Times New Roman'; font-size:12pt">in </span><span style="font-family:'Times New Roman'; font-size:12pt">a clear position to </span><span style="font-family:'Times New Roman'; font-size:12pt">request </span><span style="font-family:'Times New Roman'; font-size:12pt">a simple decla</span><span style="font-family:'Times New Roman'; font-size:12pt">ration </span><span style="font-family:'Times New Roman'; font-size:12pt">of financial conflicts of interest </span><span style="font-family:'Times New Roman'; font-size:12pt">from each doctor in the UK</span><span style="font-family:'Times New Roman'; font-size:12pt">, </span><span style="font-family:'Times New Roman'; font-size:12pt">annually, </span><span style="font-family:'Times New Roman'; font-size:12pt">and make </span><span style="font-family:'Times New Roman'; font-size:12pt">this information </span><span style="font-family:'Times New Roman'; font-size:12pt">publicly available</span><span style="font-family:'Times New Roman'; font-size:12pt"> on the register</span><span style="font-family:'Times New Roman'; font-size:12pt">.</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">3. Action on withheld trial results</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The problem of clinical trial results being </span><span style="font-family:'Times New Roman'; font-size:12pt">witheld</span><span style="font-family:'Times New Roman'; font-size:12pt">, on treatments in curren</span><span style="font-family:'Times New Roman'; font-size:12pt">t use, continues to undermine the evidence base for medicine. The best currently available evidence suggests that around half of all trials have their results withheld</span><span style="font-family:'Times New Roman'; font-size:12pt"> [7]</span><span style="font-family:'Times New Roman'; font-size:12pt">. Doctors, patients, researchers and payers cannot make informed decisions about whic</span><span style="font-family:'Times New Roman'; font-size:12pt">h treatments are best</span><span style="font-family:'Times New Roman'; font-size:12pt">,</span><span style="font-family:'Times New Roman'; font-size:12pt"> when half </span><span style="font-family:'Times New Roman'; font-size:12pt">of all </span><span style="font-family:'Times New Roman'; font-size:12pt">trial results are </span><span style="font-family:'Times New Roman'; font-size:12pt">unavailable</span><span style="font-family:'Times New Roman'; font-size:12pt">. This problem has not been adequately addressed by medical </span><span style="font-family:'Times New Roman'; font-size:12pt">and</span><span style="font-family:'Times New Roman'; font-size:12pt"> academic professional bodies, regulators, or industry. </span><span style="font-family:'Times New Roman'; font-size:12pt">There has also been a worrying trend for some in both industry and </span><span style="font-family:'Times New Roman'; font-size:12pt">medicine to give false reassurance, claiming that the problem has been fixed. This poses a significant threat to patient care.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The Science and Technology Select Committee called on the government to take action </span><span style="font-family:'Times New Roman'; font-size:12pt">over </span><span style="font-family:'Times New Roman'; font-size:12pt">this issue</span><span style="font-family:'Times New Roman'; font-size:12pt"> in September 2013</span><span style="font-family:'Times New Roman'; font-size:12pt"> [8]</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span><span style="font-family:'Times New Roman'; font-size:12pt">The H</span><span style="font-family:'Times New Roman'; font-size:12pt">ealth Committee called on the GMC </span><span style="font-family:'Times New Roman'; font-size:12pt">to take action on this issue in January </span><span style="font-family:'Times New Roman'; font-size:12pt">2013 </span><span style="font-family:'Times New Roman'; font-size:12pt">[</span><span style="font-family:'Times New Roman'; font-size:12pt">9</span><span style="font-family:'Times New Roman'; font-size:12pt">]. </span><span style="font-family:'Times New Roman'; font-size:12pt">The </span><span style="font-family:'Times New Roman'; font-size:12pt">British Medical Association</span><span style="font-family:'Times New Roman'; font-size:12pt"> passed a motion </span><span style="font-family:'Times New Roman'; font-size:12pt">in June 2013 </span><span style="font-family:'Times New Roman'; font-size:12pt">[10] [11] </span><span style="font-family:'Times New Roman'; font-size:12pt">[12] </span><span style="font-family:'Times New Roman'; font-size:12pt">stating that:</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt">“(</span><span style="font-family:'Times New Roman'; font-size:12pt">i</span><span style="font-family:'Times New Roman'; font-size:12pt">) Selective non-publication of unflattering trial data is research misconduct</span><span style="font-family:'Times New Roman'; font-size:12pt">; </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt">“</span><span style="font-family:'Times New Roman'; font-size:12pt">(ii) Registered medical practitioners who give grounds to believe they have been involved in such conduct should have their fitness to practice assessed by the GMC</span><span style="font-family:'Times New Roman'; font-size:12pt">.” </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">It would therefore be useful if the </span><span style="font-family:'Times New Roman'; font-size:12pt">GMC could </span><span style="font-family:'Times New Roman'; font-size:12pt">prominently </span><span style="font-family:'Times New Roman'; font-size:12pt">clarify their position</span><span style="font-family:'Times New Roman'; font-size:12pt">, </span><span style="font-family:'Times New Roman'; font-size:12pt">and strengthen the wording of their guidance</span><span style="font-family:'Times New Roman'; font-size:12pt">, requiring that </span><span style="font-family:'Times New Roman'; font-size:12pt">any </span><span style="font-family:'Times New Roman'; font-size:12pt">doctor</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">working on </span><span style="font-family:'Times New Roman'; font-size:12pt">a </span><span style="font-family:'Times New Roman'; font-size:12pt">trial</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">both past and present - on all treatments currently in use – </span><span style="font-family:'Times New Roman'; font-size:12pt">is </span><span style="font-family:'Times New Roman'; font-size:12pt">responsible for ensuring that the trial is </span><span style="font-family:'Times New Roman'; font-size:12pt">registered</span><span style="font-family:'Times New Roman'; font-size:12pt">,</span><span style="font-family:'Times New Roman'; font-size:12pt"> with </span><span style="font-family:'Times New Roman'; font-size:12pt">its </span><span style="font-family:'Times New Roman'; font-size:12pt">results made publicly available</span><span style="font-family:'Times New Roman'; font-size:12pt"> withi</span><span style="font-family:'Times New Roman'; font-size:12pt">n a year of completion</span><span style="font-family:'Times New Roman'; font-size:12pt">; and forbidden from entering into contracts with trial sponsors that </span><span style="font-family:'Times New Roman'; font-size:12pt">relinquish access to data </span><span style="font-family:'Times New Roman'; font-size:12pt">and prevent dissemination of results</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">While only a small proportion of doctors actively participate in conducting </span><span style="font-family:'Times New Roman'; font-size:12pt">randomised</span><span style="font-family:'Times New Roman'; font-size:12pt"> trials, a m</span><span style="font-family:'Times New Roman'; font-size:12pt">uch larger number </span><span style="font-family:'Times New Roman'; font-size:12pt">make a valuable</span><span style="font-family:'Times New Roman'; font-size:12pt"> positive</span><span style="font-family:'Times New Roman'; font-size:12pt"> contribution by </span><span style="font-family:'Times New Roman'; font-size:12pt">recruit</span><span style="font-family:'Times New Roman'; font-size:12pt">ing and encouraging </span><span style="font-family:'Times New Roman'; font-size:12pt">patients to participate </span><span style="font-family:'Times New Roman'; font-size:12pt">in others’ </span><span style="font-family:'Times New Roman'; font-size:12pt">trials research.</span><span style="font-family:'Times New Roman'; font-size:12pt"> They too have a responsibility around missing trial results.</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">Para 49d of Good Medical Practice says that doctors must work in partnership with patients, providing </span><span style="font-family:'Times New Roman'; font-size:12pt">“</span><span style="font-family:'Times New Roman'; font-size:12pt">any other information patients need if they are asked to agree to be involved in teaching or </span><span style="font-family:'Times New Roman'; font-size:12pt">research</span><span style="font-family:'Times New Roman'; font-size:12pt">”</span><span style="font-family:'Times New Roman'; font-size:12pt">. This would be greatly</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">strengthened by adding a ne</span><span style="font-family:'Times New Roman'; font-size:12pt">w clause</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">49e </span><span style="font-family:'Times New Roman'; font-size:12pt">“</span><span style="font-family:'Times New Roman'; font-size:12pt">Doctors should advise patients to</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">participate in a clinical trial only if: (1) the study protocol has been registered and made publicly available; (2) the protocol refers to systematic reviews of existing evidence showing that the trial is ju</span><span style="font-family:'Times New Roman'; font-size:12pt">stified; and (3) each patient</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">receives a written assurance that the full study results will be published and sent to all participants who indicate th</span><span style="font-family:'Times New Roman'; font-size:12pt">at they wish to receive them.</span><span style="font-family:'Times New Roman'; font-size:12pt">”</span><span style="font-family:'Times New Roman'; font-size:12pt"> [</span><span style="font-family:'Times New Roman'; font-size:12pt">13</span><span style="font-family:'Times New Roman'; font-size:12pt">] [</span><span style="font-family:'Times New Roman'; font-size:12pt">14</span><span style="font-family:'Times New Roman'; font-size:12pt">]</span></p><p style="background-color:#ffffff; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The GMC </span><span style="font-family:'Times New Roman'; font-size:12pt">do good work on misdeeds </span><span style="font-family:'Times New Roman'; font-size:12pt">by individuals </span><span style="font-family:'Times New Roman'; font-size:12pt">in individual stu</span><span style="font-family:'Times New Roman'; font-size:12pt">dies</span><span style="font-family:'Times New Roman'; font-size:12pt">. However</span><span style="font-family:'Times New Roman'; font-size:12pt">, </span><span style="font-family:'Times New Roman'; font-size:12pt">it is </span><span style="font-family:'Times New Roman'; font-size:12pt">inadequate and inconsistent to </span><span style="font-family:'Times New Roman'; font-size:12pt">only </span><span style="font-family:'Times New Roman'; font-size:12pt">hold individual studies to hig</span><span style="font-family:'Times New Roman'; font-size:12pt">h</span><span style="font-family:'Times New Roman'; font-size:12pt"> standards, </span><span style="font-family:'Times New Roman'; font-size:12pt">when </span><span style="font-family:'Times New Roman'; font-size:12pt">the biases we are seeking to exclude </span><span style="font-family:'Times New Roman'; font-size:12pt">can re-emerge</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">further down the chain</span><span style="font-family:'Times New Roman'; font-size:12pt">. </span><span style="font-family:'Times New Roman'; font-size:12pt">Even when all trials are conducted perfectly, i</span><span style="font-family:'Times New Roman'; font-size:12pt">f </span><span style="font-family:'Times New Roman'; font-size:12pt">those </span><span style="font-family:'Times New Roman'; font-size:12pt">whole studies </span><span style="font-family:'Times New Roman'; font-size:12pt">with un</span><span style="font-family:'Times New Roman'; font-size:12pt">flattering results </span><span style="font-family:'Times New Roman'; font-size:12pt">are withheld from the public record</span><span style="font-family:'Times New Roman'; font-size:12pt"> – as we know they commonly are -</span><span style="font-family:'Times New Roman'; font-size:12pt"> then we are </span><span style="font-family:'Times New Roman'; font-size:12pt">overall </span><span style="font-family:'Times New Roman'; font-size:12pt">misled on the risks and benefits of treatments</span><span style="font-family:'Times New Roman'; font-size:12pt">,</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">as surely as if the data </span><span style="font-family:'Times New Roman'; font-size:12pt">from </span><span style="font-family:'Times New Roman'; font-size:12pt">the individual studies themselves were fraudulent</span><span style="font-family:'Times New Roman'; font-size:12pt">.</span><span style="font-family:'Times New Roman'; font-size:12pt"> The GMC are in a po</span><span style="font-family:'Times New Roman'; font-size:12pt">sition to police the withholding of trial results</span><span style="font-family:'Times New Roman'; font-size:12pt">,</span><span style="font-family:'Times New Roman'; font-size:12pt"> as they </span><span style="font-family:'Times New Roman'; font-size:12pt">police </span><span style="font-family:'Times New Roman'; font-size:12pt">other forms of research misconduct.</span><span style="font-family:'Times New Roman'; font-size:12pt"> It is in patients’ interests that they should do so.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">References. </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[1] “Bad </span><span style="font-family:'Times New Roman'; font-size:12pt">Pharma</span><span style="font-family:'Times New Roman'; font-size:12pt">: how medicine is broken, and how we can fix it” Ben </span><span style="font-family:'Times New Roman'; font-size:12pt">Goldacre</span><span style="font-family:'Times New Roman'; font-size:12pt">, 4</span><span style="font-family:'Times New Roman'; font-size:8pt; vertical-align:super">th</span><span style="font-family:'Times New Roman'; font-size:12pt"> Estate, 2013</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[2] www.alltrials.net</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[3] </span><span style="font-family:'Times New Roman'; font-size:12pt">Roberts I, </span><span style="font-family:'Times New Roman'; font-size:12pt">Chaudhry</span><span style="font-family:'Times New Roman'; font-size:12pt"> B, Chalmers I. New GMC guidance takes a major, ethically flawed, backward step. BMJ. 2013;346(jun18 2):f3879–f3879. </span></p><p style="margin:0pt"><a href="http://www.bmj.com/content/346/bmj.f3879"><span style="font-family:'Times New Roman'; font-size:12pt">http://www.bmj.com/conten</span><span style="font-family:'Times New Roman'; font-size:12pt">t/346/bmj.f3879</span></a></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[4] </span><span style="font-family:'Times New Roman'; font-size:12pt">Arie</span><span style="font-family:'Times New Roman'; font-size:12pt"> S. Doctors’ groups are criticised for endorsing pro-industry guidelines. BMJ. 2013;347(oct09 2):f6066–f6066. doi:10.1136/bmj.f6066.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[5] </span><span style="font-family:'Times New Roman'; font-size:12pt">Arie</span><span style="font-family:'Times New Roman'; font-size:12pt"> S. How a marriage with big </span><span style="font-family:'Times New Roman'; font-size:12pt">pharma</span><span style="font-family:'Times New Roman'; font-size:12pt"> ended in divorce. BMJ. 2013;347(oct08 5):f6062–f6062.</span><span style="font-family:'Times New Roman'; font-size:12pt"> doi:10.1136/bmj.f6062.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[6] </span><span style="font-family:'Times New Roman'; font-size:12pt">Goldacre</span><span style="font-family:'Times New Roman'; font-size:12pt"> B, Carroll D, Hall E. Guidelines for collaboration with industry should be transparent. BMJ. 2013;347(oct09 4):f6100–f6100. doi:10.1136/bmj.f6100.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[7]</span><span style="font-family:'Times New Roman'; font-size:12pt"> </span><span style="font-family:'Times New Roman'; font-size:12pt">Huser</span><span style="font-family:'Times New Roman'; font-size:12pt"> V, </span><span style="font-family:'Times New Roman'; font-size:12pt">Cimino</span><span style="font-family:'Times New Roman'; font-size:12pt"> JJ. Linking ClinicalTrials.gov and </span><span style="font-family:'Times New Roman'; font-size:12pt">PubMed</span><span style="font-family:'Times New Roman'; font-size:12pt"> to Track R</span><span style="font-family:'Times New Roman'; font-size:12pt">esults of Interventional Human Clinical Trials. </span><span style="font-family:'Times New Roman'; font-size:12pt">PLoS</span><span style="font-family:'Times New Roman'; font-size:12pt"> ONE. 2013;8(7):e68409. doi:10.1371/journal.pone.0068409.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[8] </span><span style="font-family:'Times New Roman'; font-size:12pt">Science and Technology Committee, Third Report, Clinical Trials, 9 September 2013. </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">http://www.parliament.uk/business/committees/committees-a-</span><span style="font-family:'Times New Roman'; font-size:12pt">z/commons-select/science-and-technology-committee/news/130916-clinical-trials-report-published/</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[9] </span><span style="font-family:'Times New Roman'; font-size:12pt">Health Committee, </span><span style="font-family:'Times New Roman'; font-size:12pt">Eighth </span><span style="font-family:'Times New Roman'; font-size:12pt">Report, National Institute for Health and Clinical Excellence, </span><span style="font-family:'Times New Roman'; font-size:12pt">16 </span><span style="font-family:'Times New Roman'; font-size:12pt">January 2013. </span><span style="font-family:'Times New Roman'; font-size:12pt">http://www.parliament.uk/business/committees/commit</span><span style="font-family:'Times New Roman'; font-size:12pt">tees-a-z/commons-select/health-committee/news/13-01-15/</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[</span><span style="font-family:'Times New Roman'; font-size:12pt">10</span><span style="font-family:'Times New Roman'; font-size:12pt">] </span><a href="http://bma.org.uk/working-for-change/improving-and-protecting-health/clinical-trials"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:12pt; text-decoration:underline">http://bma.org.uk/working-for-change/improving-and-protecting-health/clinical-trials</span></a><span style="font-family:'Times New Roman'; font-size:12pt"> </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[11</span><span style="font-family:'Times New Roman'; font-size:12pt">] </span><a href="http://ecancer.org/journal/news/4200-bma-----non-publication-of-trials-results-is-research-misconduct.php"><span style="font-family:'Times New Roman'; font-size:12pt">http://ecancer.org/journal/news/4200-bma-----non-publication-of-trials-results-is-research-misconduct.php</span></a><span style="font-family:'Times New Roman'; font-size:12pt"> </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[1</span><span style="font-family:'Times New Roman'; font-size:12pt">2</span><span style="font-family:'Times New Roman'; font-size:12pt">] </span><a href="http://www.alltrials.net/2013/bma-votes-that-non-publication-of-trials-results-is-research-misconduct/"><span style="font-family:'Times New Roman'; font-size:12pt">http://www.alltrials.net/2013/bma-votes-that-non-publication-of-trials-results-is-research-misconduct/</span></a></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[13] Chalmers I,</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">Glasziou</span><span style="font-family:'Times New Roman'; font-size:12pt"> P,</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">Godlee</span><span style="font-family:'Times New Roman'; font-size:12pt"> F. All trials must </span><span style="font-family:'Times New Roman'; font-size:12pt">be registered and the results published.</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">BMJ</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">2013;346:f105</span></p><p style="background-color:#ffffff; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">[14]</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">Evans I, Thornton H, Chalmers I, </span><span style="font-family:'Times New Roman'; font-size:12pt">Glasziou</span><span style="font-family:'Times New Roman'; font-size:12pt"> P. Testing treatments. Pinter and Martin, 2011.</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><a href="http://www.testingtreatments.org/" target="_blank"><span style="font-family:'Times New Roman'; font-size:12pt">www.testingtreatments.org</span></a><span style="font-family:'Times New Roman'; font-size:12pt">.</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic">December 2013</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:Cambria; font-size:12pt">&#xa0;</span></p></div></body></html>